Keros Therapeutics
KROS
KROS
49 hedge funds and large institutions have $454M invested in Keros Therapeutics in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 51 → 49 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
49
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$46.3M | |
| 2 | +$16.5M | |
| 3 | +$3.22M | |
| 4 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
+$985K |
| 5 |
Goldman Sachs
New York
|
+$683K |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$8.26M | |
| 3 | -$5.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.39M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.76M |